Clinical Trial Update: Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing everolimus (RAD001) as monotherapy with best supportive care in advanced gastric cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Advanced Gastric Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-04-06